We are live on ! Find out more
SRTA

Strata Critical Medical Inc

96 hedge funds and large institutions have $140M invested in Strata Critical Medical Inc in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.32% more ownership

Funds ownership: 54.22%54.54% (+0.32%)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

3% less funds holding

Funds holding: 9996 (-3)

10% less capital invested

Capital invested by funds: $156M → $140M (-$16.1M)

12% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $1.48M

27% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 33

Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
1.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
24
Reduced
33
Closed
11
Calls
$1.3M
Puts
$1.48M
Net Calls
-$176K
Net Calls Change
-$11K
Name Holding Trade Value Shares
Change
Change in
Stake
HVCM
1
HG Vora Capital Management
New York
$28.2M
AIM
2
ARK Investment Management
Florida
$25.1M -$1.36M -318,535 -4%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$17.3M -$138K -32,366 -0.7%
NAMA
4
Nikko Asset Management Americas
New York
$17.3M -$138K -32,366 -0.7%
BlackRock
5
BlackRock
New York
$13.3M -$9.29K -2,175 -0.1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$10M -$12.7K -2,978 -0.1%
State Street
7
State Street
Massachusetts
$4.35M -$40.5K -9,477 -0.8%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.54M +$128K +29,902 +3%
EMG
9
ETF Managers Group
New Jersey
$2.82M +$445K +104,102 +15%
BGIM
10
Brandywine Global Investment Management
Pennsylvania
$1.89M
Northern Trust
11
Northern Trust
Illinois
$1.59M -$31K -7,243 -2%
AWS
12
AJ Wealth Strategies
New York
$1.33M
CSCSIM
13
Clear Sky Carbon Solutions Investment Management
Texas
$1.29M +$1.54M +360,000 New
DRS
14
Deane Retirement Strategies
Louisiana
$887K +$492K +115,211 +87%
N
15
Nuveen
North Carolina
$664K -$92.3K -21,601 -10%
IP
16
Intellectus Partners
California
$654K +$73.5K +17,210 +10%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$621K +$18.6K +4,349 +3%
QOP
18
Quinn Opportunity Partners
Virginia
$611K
ICM
19
Ionic Capital Management
New York
$547K +$314K +73,408 +93%
Charles Schwab
20
Charles Schwab
California
$517K +$15.4K +3,614 +3%
BFM
21
Boothbay Fund Management
New York
$514K +$613K +143,493 New
Citadel Advisors
22
Citadel Advisors
Florida
$502K +$56.5K +13,227 +10%
AGC
23
Aspen Grove Capital
Colorado
$448K +$534K +125,000 New
SAM
24
Stansberry Asset Management
Texas
$372K +$10.2K +2,391 +2%
Renaissance Technologies
25
Renaissance Technologies
New York
$363K +$230K +53,783 +113%

SRTA Hedge Fund Activity: Q4 2022 in Review

96 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q4 2022, worth a combined $140M — down 10% from $156M a quarter earlier.

Fund positioning in SRTA was balanced in Q4 2022: 11 funds opened new positions, 11 closed out, 24 added to existing stakes and 33 trimmed.

The largest buyer was Clear Sky Carbon Solutions Investment Management, opening a new position worth an estimated $1.54M. The largest seller was ARK Investment Management, cutting an estimated $1.36M.

  • 96 institutional investors held Strata Critical Medical Inc (SRTA) as of Q4 2022, down from 99 in Q3 2022.
  • Funds reported $140M of Strata Critical Medical Inc stock for Q4 2022, down 10% quarter-over-quarter.
  • 11 funds opened new Strata Critical Medical Inc positions in Q4 2022 and 11 closed out, a net change of 0 holders.
  • The largest Strata Critical Medical Inc buyer in Q4 2022 was Clear Sky Carbon Solutions Investment Management, an estimated $1.54M added.
  • The largest Strata Critical Medical Inc seller in Q4 2022 was ARK Investment Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2022.